table of content
1 Introduction to Research & Analysis Reports
1.1 B Cell Maturation Antigen Targeted Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global B Cell Maturation Antigen Targeted Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global B Cell Maturation Antigen Targeted Therapy Overall Market Size
2.1 Global B Cell Maturation Antigen Targeted Therapy Market Size: 2022 VS 2029
2.2 Global B Cell Maturation Antigen Targeted Therapy Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top B Cell Maturation Antigen Targeted Therapy Players in Global Market
3.2 Top Global B Cell Maturation Antigen Targeted Therapy Companies Ranked by Revenue
3.3 Global B Cell Maturation Antigen Targeted Therapy Revenue by Companies
3.4 Top 3 and Top 5 B Cell Maturation Antigen Targeted Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies B Cell Maturation Antigen Targeted Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 B Cell Maturation Antigen Targeted Therapy Players in Global Market
3.6.1 List of Global Tier 1 B Cell Maturation Antigen Targeted Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 B Cell Maturation Antigen Targeted Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global B Cell Maturation Antigen Targeted Therapy Market Size Markets, 2022 & 2029
4.1.2 Antibody-Drug Conjugates
4.1.3 CAR-T Cells and Bispecific T Cell Engagers
4.2 By Type - Global B Cell Maturation Antigen Targeted Therapy Revenue & Forecasts
4.2.1 By Type - Global B Cell Maturation Antigen Targeted Therapy Revenue, 2018-2023
4.2.2 By Type - Global B Cell Maturation Antigen Targeted Therapy Revenue, 2024-2029
4.2.3 By Type - Global B Cell Maturation Antigen Targeted Therapy Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global B Cell Maturation Antigen Targeted Therapy Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application - Global B Cell Maturation Antigen Targeted Therapy Revenue & Forecasts
5.2.1 By Application - Global B Cell Maturation Antigen Targeted Therapy Revenue, 2018-2023
5.2.2 By Application - Global B Cell Maturation Antigen Targeted Therapy Revenue, 2024-2029
5.2.3 By Application - Global B Cell Maturation Antigen Targeted Therapy Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global B Cell Maturation Antigen Targeted Therapy Market Size, 2022 & 2029
6.2 By Region - Global B Cell Maturation Antigen Targeted Therapy Revenue & Forecasts
6.2.1 By Region - Global B Cell Maturation Antigen Targeted Therapy Revenue, 2018-2023
6.2.2 By Region - Global B Cell Maturation Antigen Targeted Therapy Revenue, 2024-2029
6.2.3 By Region - Global B Cell Maturation Antigen Targeted Therapy Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America B Cell Maturation Antigen Targeted Therapy Revenue, 2018-2029
6.3.2 US B Cell Maturation Antigen Targeted Therapy Market Size, 2018-2029
6.3.3 Canada B Cell Maturation Antigen Targeted Therapy Market Size, 2018-2029
6.3.4 Mexico B Cell Maturation Antigen Targeted Therapy Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe B Cell Maturation Antigen Targeted Therapy Revenue, 2018-2029
6.4.2 Germany B Cell Maturation Antigen Targeted Therapy Market Size, 2018-2029
6.4.3 France B Cell Maturation Antigen Targeted Therapy Market Size, 2018-2029
6.4.4 U.K. B Cell Maturation Antigen Targeted Therapy Market Size, 2018-2029
6.4.5 Italy B Cell Maturation Antigen Targeted Therapy Market Size, 2018-2029
6.4.6 Russia B Cell Maturation Antigen Targeted Therapy Market Size, 2018-2029
6.4.7 Nordic Countries B Cell Maturation Antigen Targeted Therapy Market Size, 2018-2029
6.4.8 Benelux B Cell Maturation Antigen Targeted Therapy Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia B Cell Maturation Antigen Targeted Therapy Revenue, 2018-2029
6.5.2 China B Cell Maturation Antigen Targeted Therapy Market Size, 2018-2029
6.5.3 Japan B Cell Maturation Antigen Targeted Therapy Market Size, 2018-2029
6.5.4 South Korea B Cell Maturation Antigen Targeted Therapy Market Size, 2018-2029
6.5.5 Southeast Asia B Cell Maturation Antigen Targeted Therapy Market Size, 2018-2029
6.5.6 India B Cell Maturation Antigen Targeted Therapy Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America B Cell Maturation Antigen Targeted Therapy Revenue, 2018-2029
6.6.2 Brazil B Cell Maturation Antigen Targeted Therapy Market Size, 2018-2029
6.6.3 Argentina B Cell Maturation Antigen Targeted Therapy Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa B Cell Maturation Antigen Targeted Therapy Revenue, 2018-2029
6.7.2 Turkey B Cell Maturation Antigen Targeted Therapy Market Size, 2018-2029
6.7.3 Israel B Cell Maturation Antigen Targeted Therapy Market Size, 2018-2029
6.7.4 Saudi Arabia B Cell Maturation Antigen Targeted Therapy Market Size, 2018-2029
6.7.5 UAE B Cell Maturation Antigen Targeted Therapy Market Size, 2018-2029
7 B Cell Maturation Antigen Targeted Therapy Companies Profiles
7.1 GlaxoSmithKline
7.1.1 GlaxoSmithKline Company Summary
7.1.2 GlaxoSmithKline Business Overview
7.1.3 GlaxoSmithKline B Cell Maturation Antigen Targeted Therapy Major Product Offerings
7.1.4 GlaxoSmithKline B Cell Maturation Antigen Targeted Therapy Revenue in Global Market (2018-2023)
7.1.5 GlaxoSmithKline Key News & Latest Developments
7.2 Johnson & Johnson
7.2.1 Johnson & Johnson Company Summary
7.2.2 Johnson & Johnson Business Overview
7.2.3 Johnson & Johnson B Cell Maturation Antigen Targeted Therapy Major Product Offerings
7.2.4 Johnson & Johnson B Cell Maturation Antigen Targeted Therapy Revenue in Global Market (2018-2023)
7.2.5 Johnson & Johnson Key News & Latest Developments
7.3 Amgen
7.3.1 Amgen Company Summary
7.3.2 Amgen Business Overview
7.3.3 Amgen B Cell Maturation Antigen Targeted Therapy Major Product Offerings
7.3.4 Amgen B Cell Maturation Antigen Targeted Therapy Revenue in Global Market (2018-2023)
7.3.5 Amgen Key News & Latest Developments
7.4 Seagen
7.4.1 Seagen Company Summary
7.4.2 Seagen Business Overview
7.4.3 Seagen B Cell Maturation Antigen Targeted Therapy Major Product Offerings
7.4.4 Seagen B Cell Maturation Antigen Targeted Therapy Revenue in Global Market (2018-2023)
7.4.5 Seagen Key News & Latest Developments
7.5 AbbVie
7.5.1 AbbVie Company Summary
7.5.2 AbbVie Business Overview
7.5.3 AbbVie B Cell Maturation Antigen Targeted Therapy Major Product Offerings
7.5.4 AbbVie B Cell Maturation Antigen Targeted Therapy Revenue in Global Market (2018-2023)
7.5.5 AbbVie Key News & Latest Developments
7.6 Novartis
7.6.1 Novartis Company Summary
7.6.2 Novartis Business Overview
7.6.3 Novartis B Cell Maturation Antigen Targeted Therapy Major Product Offerings
7.6.4 Novartis B Cell Maturation Antigen Targeted Therapy Revenue in Global Market (2018-2023)
7.6.5 Novartis Key News & Latest Developments
7.7 BioTherapeutics
7.7.1 BioTherapeutics Company Summary
7.7.2 BioTherapeutics Business Overview
7.7.3 BioTherapeutics B Cell Maturation Antigen Targeted Therapy Major Product Offerings
7.7.4 BioTherapeutics B Cell Maturation Antigen Targeted Therapy Revenue in Global Market (2018-2023)
7.7.5 BioTherapeutics Key News & Latest Developments
7.8 Celgene
7.8.1 Celgene Company Summary
7.8.2 Celgene Business Overview
7.8.3 Celgene B Cell Maturation Antigen Targeted Therapy Major Product Offerings
7.8.4 Celgene B Cell Maturation Antigen Targeted Therapy Revenue in Global Market (2018-2023)
7.8.5 Celgene Key News & Latest Developments
7.9 Bluebird Bio
7.9.1 Bluebird Bio Company Summary
7.9.2 Bluebird Bio Business Overview
7.9.3 Bluebird Bio B Cell Maturation Antigen Targeted Therapy Major Product Offerings
7.9.4 Bluebird Bio B Cell Maturation Antigen Targeted Therapy Revenue in Global Market (2018-2023)
7.9.5 Bluebird Bio Key News & Latest Developments
7.10 Bristol Mayer Squibb
7.10.1 Bristol Mayer Squibb Company Summary
7.10.2 Bristol Mayer Squibb Business Overview
7.10.3 Bristol Mayer Squibb B Cell Maturation Antigen Targeted Therapy Major Product Offerings
7.10.4 Bristol Mayer Squibb B Cell Maturation Antigen Targeted Therapy Revenue in Global Market (2018-2023)
7.10.5 Bristol Mayer Squibb Key News & Latest Developments
7.11 Carsgen Therapeutics
7.11.1 Carsgen Therapeutics Company Summary
7.11.2 Carsgen Therapeutics Business Overview
7.11.3 Carsgen Therapeutics B Cell Maturation Antigen Targeted Therapy Major Product Offerings
7.11.4 Carsgen Therapeutics B Cell Maturation Antigen Targeted Therapy Revenue in Global Market (2018-2023)
7.11.5 Carsgen Therapeutics Key News & Latest Developments
7.12 Juno Therapeutics
7.12.1 Juno Therapeutics Company Summary
7.12.2 Juno Therapeutics Business Overview
7.12.3 Juno Therapeutics B Cell Maturation Antigen Targeted Therapy Major Product Offerings
7.12.4 Juno Therapeutics B Cell Maturation Antigen Targeted Therapy Revenue in Global Market (2018-2023)
7.12.5 Juno Therapeutics Key News & Latest Developments
7.13 Cogent Bioscience
7.13.1 Cogent Bioscience Company Summary
7.13.2 Cogent Bioscience Business Overview
7.13.3 Cogent Bioscience B Cell Maturation Antigen Targeted Therapy Major Product Offerings
7.13.4 Cogent Bioscience B Cell Maturation Antigen Targeted Therapy Revenue in Global Market (2018-2023)
7.13.5 Cogent Bioscience Key News & Latest Developments
7.14 CRISPR Therapeutics
7.14.1 CRISPR Therapeutics Company Summary
7.14.2 CRISPR Therapeutics Business Overview
7.14.3 CRISPR Therapeutics B Cell Maturation Antigen Targeted Therapy Major Product Offerings
7.14.4 CRISPR Therapeutics B Cell Maturation Antigen Targeted Therapy Revenue in Global Market (2018-2023)
7.14.5 CRISPR Therapeutics Key News & Latest Developments
7.15 Allogene Therapeutics
7.15.1 Allogene Therapeutics Company Summary
7.15.2 Allogene Therapeutics Business Overview
7.15.3 Allogene Therapeutics B Cell Maturation Antigen Targeted Therapy Major Product Offerings
7.15.4 Allogene Therapeutics B Cell Maturation Antigen Targeted Therapy Revenue in Global Market (2018-2023)
7.15.5 Allogene Therapeutics Key News & Latest Developments
7.16 Harpoon Therapeutics
7.16.1 Harpoon Therapeutics Company Summary
7.16.2 Harpoon Therapeutics Business Overview
7.16.3 Harpoon Therapeutics B Cell Maturation Antigen Targeted Therapy Major Product Offerings
7.16.4 Harpoon Therapeutics B Cell Maturation Antigen Targeted Therapy Revenue in Global Market (2018-2023)
7.16.5 Harpoon Therapeutics Key News & Latest Developments
7.17 Poseida Therapeutics
7.17.1 Poseida Therapeutics Company Summary
7.17.2 Poseida Therapeutics Business Overview
7.17.3 Poseida Therapeutics B Cell Maturation Antigen Targeted Therapy Major Product Offerings
7.17.4 Poseida Therapeutics B Cell Maturation Antigen Targeted Therapy Revenue in Global Market (2018-2023)
7.17.5 Poseida Therapeutics Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
